Insulin Infusion System
Artificial pancreas improves time in range vs. insulin pump therapy
Children and adults with type 1 diabetes assigned to an artificial pancreas for 6 months spent an average of 2.6 fewer hours per day in hyperglycemia and 13 fewer minutes per day in hypoglycemia when compared with participants using sensor-augmented insulin pump therapy, according to findings published in The New England Journal of Medicine.
Top takeaways from AADE 2019
Endocrine Today has compiled a list of the top five news reports posted from American Association of Diabetes Educators annual meeting, held August 9-12, 2019, in Houston.
Medtronic receives FDA investigational approval for testing of longer-use insulin infusion set
The FDA approved on Friday a proposed trial of an insulin infusion set that can be worn for 7 days, according to a press release from Medtronic.
Hybrid closed-loop insulin system well tolerated, effective for lowering HbA1c
HOUSTON — A retrospective chart review of adults with type 1 diabetes who used the Medtronic MiniMed 670G revealed generally favorable experiences with the technology as well as improvements in HbA1c, according to findings presented at the American Association of Diabetes Educators annual meeting.